Resource Type

Journal Article 139

Conference Videos 10

Year

2024 1

2023 17

2022 20

2021 23

2020 19

2019 2

2018 9

2017 14

2016 12

2015 8

2014 2

2013 1

2012 6

2011 1

2010 3

2009 3

2008 1

2007 1

2003 1

2000 1

open ︾

Keywords

COVID-19 5

Emerging contaminants 5

strategic emerging industries 5

China 3

emerging industries 3

14th Five-Year Plan 2

2035 2

Adsorption 2

Ebola virus 2

Emerging organic contaminants 2

Gut microbiota 2

Infectious disease 2

Microbiome 2

emerging industry 2

13th Five-Year Plan 1

21-gene assay 1

3D reconstruction 1

Corymbia 1

Eucalyptus 1

open ︾

Search scope:

排序： Display mode:

Responses to emerging and re-emerging infectious diseases: One world, One health

Jianqing Xu, Jianguo Xu

Frontiers of Medicine 2018, Volume 12, Issue 1,   Pages 1-2 doi: 10.1007/s11684-018-0619-y

HTML PDF Collect

Landscape of emerging and re-emerging infectious diseases in China: impact of ecology, climate, and behavior

Qiyong Liu, Wenbo Xu, Shan Lu, Jiafu Jiang, Jieping Zhou, Zhujun Shao, Xiaobo Liu, Lei Xu, Yanwen Xiong, Han Zheng, Sun Jin, Hai Jiang, Wuchun Cao, Jianguo Xu

Frontiers of Medicine 2018, Volume 12, Issue 1,   Pages 3-22 doi: 10.1007/s11684-017-0605-9

Abstract: Notably, 5 notifiable infectious diseases have been almost eradicated, and the incidence of 18 additionalnotifiable infectious diseases has been significantly reduced.imported infectious diseases have increased since 2015.This review summarizes the current experiences and lessons from China in managing emerging and re-emergingin helping other countries to control and prevent infectious diseases.

Keywords： infectious disease profile     emerging infectious diseases     influence factor    

HTML PDF Collect

Human monoclonal antibodies as candidate therapeutics against emerging viruses

Yujia Jin, Cheng Lei, Dan Hu, Dimiter S. Dimitrov, Tianlei Ying

Frontiers of Medicine 2017, Volume 11, Issue 4,   Pages 462-470 doi: 10.1007/s11684-017-0596-6

Abstract: Monoclonal antibodies (mAbs) have been successfully used to treat various diseases, particularly cancerConsequently, an increasing number of mAbs, which exhibit high potency against emerging viruses production, and discuss the potential use of such strategies for the development of antivirals against emergingdiseases.viral diseases.

Keywords： human monoclonal antibodies     emerging infectious diseases     SARS-CoV     MERS-CoV     Ebola virus    

HTML PDF Collect

Ecological Barrier Deterioration Driven by Human Activities Poses Fatal Threats to Public Health due to EmergingInfectious Diseases Review

Dayi Zhang,Yunfeng Yang,Miao Li,Yun Lu,Yi Liu,Jingkun Jiang,Ruiping Liu,Jianguo Liu,Xia Huang,Guanghe Li,Jiuhui Qu,

Engineering 2022, Volume 10, Issue 3,   Pages 155-166 doi: 10.1016/j.eng.2020.11.002

Abstract: These emerging infectious diseases threaten global public health and raise urgent studies on unravelinginfectious diseases, both types of barriers play synergistic roles in wildlife habitats.Global climate change can trigger and expand the range of emerging infectious diseases, and human disturbancesinfectious diseases.infectious diseases to public health.

Keywords： Emerging infectious diseases     Virus     Ecological barrier    

HTML PDF Collect

Passive antibody therapy in emerging infectious diseases

Frontiers of Medicine doi: 10.1007/s11684-023-1021-y

Abstract: antibody therapy against VOCs was assessed, offering insights into the coping strategies for facing new infectious

Keywords： SARS-CoV-2     COVID-19     convalescent plasma     hyperimmunoglobulin     neutralizing monoclonal antibodies    

HTML PDF Collect

triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectiousdiseases

Changlin Cao, Jingxian Gu, Jingyao Zhang

Frontiers of Medicine 2017, Volume 11, Issue 2,   Pages 169-177 doi: 10.1007/s11684-017-0505-z

Abstract: Sensitive and useful biomarkers for the diagnosis and prognosis of infectious diseases have been widelydiseases. sTREM-1 level can be potentially used for the early diagnosis and prognosis prediction ofsome infectious diseases, including infectious pleural effusion, lung infections, sepsis, bacterial meningitisdiseases.diseases.

Keywords： soluble triggering receptor expressed on myeloid cells-1     infectious diseases     diagnosis and prognosis    

HTML PDF Collect

Unusual global outbreak of monkeypox: what should we do?

Frontiers of Medicine 2022, Volume 16, Issue 4,   Pages 507-517 doi: 10.1007/s11684-022-0952-z

Abstract: Recently, monkeypox has become a global concern amid the ongoing COVID-19 pandemic. Monkeypox is an acute rash zoonosis caused by the monkeypox virus, which was previously concentrated in Africa. The re-emergence of this pathogen seems unusual on account of outbreaks in multiple nonendemic countries and the incline to spread from person to person. We need to revisit this virus to prevent the epidemic from getting worse. In this review, we comprehensively summarize studies on monkeypox, including its epidemiology, biological characteristics, pathogenesis, and clinical characteristics, as well as therapeutics and vaccines, highlighting its unusual outbreak attributed to the transformation of transmission. We also analyze the present situation and put forward countermeasures from both clinical and scientific research to address it.

Keywords： monkeypox     poxviruses     vaccine     infectious diseases    

HTML PDF Collect

Nucleic acid-based diagnostics for infectious diseases in public health affairs

Albert Cheung-Hoi Yu, Greg Vatcher, Xin Yue, Yan Dong, Mao Hua Li, Patrick H. K. Tam, Parker Y.L. Tsang, April K.Y. Wong, Michael H.K. Hui, Bin Yang, Hao Tang, Lok-Ting Lau

Frontiers of Medicine 2012, Volume 6, Issue 2,   Pages 173-186 doi: 10.1007/s11684-012-0195-5

Abstract:

Infectious diseases, mostly caused by bacteria and viruses but also a result of fungal and parasitic, biochemical tests and serological tests, to help detect and fight against the causative agents of diseases

Keywords： nucleic acid-based diagnostics     infectious disease     PCR     NASBA     LAMP     microarray     LOAC     public health affairs    

HTML PDF Collect

A Study on the Development Strategy for the Prevention of Infectious Diseases in China

Li Lanjuan,Zhang Boli,Xu Jianguo,Du Weibo,Xiao Yonghong,Ma Weihang,Zhang Jianzhong and Zhang Junhua

Strategic Study of CAE 2017, Volume 19, Issue 2,   Pages 37-42 doi: 10.15302/J-SSCAE-2017.02.006

Abstract: diseases in China.diseases that are adaptable to China’s specific national conditions.This paper analyzes the epidemic situation and the prevention and control of infectious diseases in Chinadiseases.diseases in China.

Keywords： infectious diseases     regulatory system     prevention-and-control research     strategic suggestion    

HTML PDF Collect

Transforming bacterial disease surveillance and investigation using whole-genome sequence to probe the trace

Biao Kan, Haijian Zhou, Pengcheng Du, Wen Zhang, Xin Lu, Tian Qin, Jianguo Xu

Frontiers of Medicine 2018, Volume 12, Issue 1,   Pages 23-33 doi: 10.1007/s11684-017-0607-7

Abstract: expedited the application of strategy and methodology for bacterial genome comparison used in dissection of infectiousWide applications of genome sequencing and data sharing in infectious disease surveillance networks willconsiderably promote outbreak detection and early warning to prevent the dissemination of bacterial diseases

Keywords： genome sequencing     genomic epidemiology     bacteria     surveillance     infectious diseases    

HTML PDF Collect

PulseNet China, a model for future laboratory-based bacterial infectious disease surveillance in China

Wei Li, Shan Lu, Zhigang Cui, Jinghua Cui, Haijian Zhou, Yiqing Wang, Zhujun Shao, Changyun Ye, Biao Kan, Jianguo Xu

Frontiers of Medicine 2012, Volume 6, Issue 4,   Pages 366-375 doi: 10.1007/s11684-012-0214-6

Abstract:

Surveillance is critical for the prevention and control of infectious disease.China’s real-time web-based infectious disease reporting system is a distinguished achievement.However, many aspects of the current China Infectious Disease Surveillance System do not yet meet thedemand for timely outbreak detection and identification of emerging infectious disease.PulseNet to develop a model for a future national laboratory-based surveillance system for all bacterial infectious

Keywords： infectious disease     laboratory-based infectious disease surveillance     pulse field gel electrophoresis     multilocus    

HTML PDF Collect

The Human Microbiota in Health and Disease

Baohong Wang, Mingfei Yao, Longxian Lv, Zongxin Ling, Lanjuan Li

Engineering 2017, Volume 3, Issue 1,   Pages 71-82 doi: 10.1016/J.ENG.2017.01.008

Abstract: microbial role in basic biological processes and in the development and progression of major human diseasessuch as infectious diseases, liver diseases, gastrointestinal cancers, metabolic diseases, respiratorydiseases, mental or psychological diseases, and autoimmune diseases.

Keywords： Microbiome     Health     Infectious disease     Liver diseases     Gastrointestinal malignancy     Metabolic disorder     Microbiota    

HTML PDF Collect

Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions

Zhiruo Zhang, Shelan Liu, Mi Xiang, Shijian Li, Dahai Zhao, Chaolin Huang, Saijuan Chen

Frontiers of Medicine 2020, Volume 14, Issue 2,   Pages 229-231 doi: 10.1007/s11684-020-0765-x

Abstract: to reduce infection among HCP, and also made suggestions for improving occupational safety during an infectious

Keywords： healthcare personnel     COVID-19     infectious diseases    

HTML PDF Collect

Vented Individual Patient (VIP) Hoods for the Control of Infectious Airborne Diseases in Healthcare Facilities Review

J. Patel, F. McGain, T. Bhatelia, S. Wang, B. Sun, J. Monty, V. Pareek

Engineering 2022, Volume 15, Issue 8,   Pages 126-132 doi: 10.1016/j.eng.2020.12.024

Abstract:

By providing a means of separating the airborne emissions of patients from the air breathed by healthcare workers (HCWs), vented individual patient (VIP) hoods, a form of local exhaust ventilation (LEV), offer a new approach to reduce hospital-acquired infection (HAI). Results from recent studies have demonstrated that, for typical patient-emitted aerosols, VIP hoods provide protection at least equivalent to that of an N95 mask. Unlike a mask, hood performance can be easily monitored and HCWs can be alerted to failure by alarms. The appropriate use of these relatively simple devices could both reduce the reliance on personal protective equipment (PPE) for infection control and provide a low-cost and energy-efficient form of protection for hospitals and clinics. Although the development and deployment of VIP hoods has been accelerated by the coronavirus disease 2019 (COVID-19) pandemic, these devices are currently an immature technology. In this review, we describe the state of the art of VIP hoods and identify aspects in need of further development, both in terms of device design and the protocols associated with their use. The broader concept of individual patient hoods has the potential to be expanded beyond ventilation to the provision of clean conditions for individual patients and personalized control over other environmental factors such as temperature and humidity.

Keywords： COVID-19     Vented individual patient hood     Airborne transmission     Healthcare worker     Infectious disease    

HTML PDF Collect

Toll-like receptors in innate immunity and infectious diseases

Min-Hao WU, Ping ZHANG, Xi HUANG,

Frontiers of Medicine 2010, Volume 4, Issue 4,   Pages 385-393 doi: 10.1007/s11684-010-0600-x

Abstract: TLRs in the innate immune system have implications for the prevention and treatment of a variety of infectiousdiseases, including tuberculosis (TB), microbial keratitis, and hepatitis B and C.

Keywords： Toll-like receptors     innate immunity     infectious disease     inflammation    

HTML PDF Collect

Title Author Date Type Operation

Responses to emerging and re-emerging infectious diseases: One world, One health

Jianqing Xu, Jianguo Xu

Journal Article

Landscape of emerging and re-emerging infectious diseases in China: impact of ecology, climate, and behavior

Qiyong Liu, Wenbo Xu, Shan Lu, Jiafu Jiang, Jieping Zhou, Zhujun Shao, Xiaobo Liu, Lei Xu, Yanwen Xiong, Han Zheng, Sun Jin, Hai Jiang, Wuchun Cao, Jianguo Xu

Journal Article

Human monoclonal antibodies as candidate therapeutics against emerging viruses

Yujia Jin, Cheng Lei, Dan Hu, Dimiter S. Dimitrov, Tianlei Ying

Journal Article

Ecological Barrier Deterioration Driven by Human Activities Poses Fatal Threats to Public Health due to EmergingInfectious Diseases

Dayi Zhang,Yunfeng Yang,Miao Li,Yun Lu,Yi Liu,Jingkun Jiang,Ruiping Liu,Jianguo Liu,Xia Huang,Guanghe Li,Jiuhui Qu,

Journal Article

Passive antibody therapy in emerging infectious diseases

Journal Article

triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectiousdiseases

Changlin Cao, Jingxian Gu, Jingyao Zhang

Journal Article

Unusual global outbreak of monkeypox: what should we do?

Journal Article

Nucleic acid-based diagnostics for infectious diseases in public health affairs

Albert Cheung-Hoi Yu, Greg Vatcher, Xin Yue, Yan Dong, Mao Hua Li, Patrick H. K. Tam, Parker Y.L. Tsang, April K.Y. Wong, Michael H.K. Hui, Bin Yang, Hao Tang, Lok-Ting Lau

Journal Article

A Study on the Development Strategy for the Prevention of Infectious Diseases in China

Li Lanjuan,Zhang Boli,Xu Jianguo,Du Weibo,Xiao Yonghong,Ma Weihang,Zhang Jianzhong and Zhang Junhua

Journal Article

Transforming bacterial disease surveillance and investigation using whole-genome sequence to probe the trace

Biao Kan, Haijian Zhou, Pengcheng Du, Wen Zhang, Xin Lu, Tian Qin, Jianguo Xu

Journal Article

PulseNet China, a model for future laboratory-based bacterial infectious disease surveillance in China

Wei Li, Shan Lu, Zhigang Cui, Jinghua Cui, Haijian Zhou, Yiqing Wang, Zhujun Shao, Changyun Ye, Biao Kan, Jianguo Xu

Journal Article

The Human Microbiota in Health and Disease

Baohong Wang, Mingfei Yao, Longxian Lv, Zongxin Ling, Lanjuan Li

Journal Article

Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions

Zhiruo Zhang, Shelan Liu, Mi Xiang, Shijian Li, Dahai Zhao, Chaolin Huang, Saijuan Chen

Journal Article

Vented Individual Patient (VIP) Hoods for the Control of Infectious Airborne Diseases in Healthcare Facilities

J. Patel, F. McGain, T. Bhatelia, S. Wang, B. Sun, J. Monty, V. Pareek

Journal Article

Toll-like receptors in innate immunity and infectious diseases

Min-Hao WU, Ping ZHANG, Xi HUANG,

Journal Article